Accepting New Patients
Swarup Kumar, MBBS
Blood and Marrow Transplant and Cellular Therapy|
Hematology|
Leukemia|
Lymphoma|
Malignant Hematology|
Multiple Myeloma
Speaks: English, Tamil
Care Provided
Locations
Neag Comprehensive Cancer Center
UConn Health
Outpatient Pavilion, 4th Floor
263 Farmington Avenue
Farmington, CT 06030
GPS: 135 Dowling Way, Farmington, CT
860-679-2100
Education & Training
Education
MBBS, Jawaharial Institute of Post Medical Education and Research, Bachelor of Medicine and Surgery - 2013
Residency
Internal Medicine, Saint Vincent Hospital - 2018
Fellowship
Hematology/Oncology, UConn School of Medicine - 2021
Board Certification
Internal Medicine
Honors & Awards
2022 - Teaching award for Excellence in Education - Hematology and Medical Oncology Fellowship Program
Clinical Trials
- A Phase 3 Randomized Study Comparing Teclistamab Monotherapy versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants with Relapsed or Refractory Multiple Myeloma who have Received 1 to 3 Prior Lines of Therapy, Including an Anti-CD38 Monoclonal Antibody and Lenalidomide (MajesTEC-9)
- A Phase 3, Two-Stage, Randomized, Multicenter, Open-label Study Comparing Mezigdomide(CC-92480), Bortezomib, and Dexamethasone (MeziVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM): Successor-1